The vaccine currently in use is a Meningococcal Polysaccharides, Immunity after one vaccination lasts for three years. (MENINGOCOCCAL POLYSACCHARIDE VACCINE A+C).
MenACWY vaccine. The MenACWY vaccine offers protection against 4 types of bacteria that can cause meningitis: meningococcal groups A, C, W and Y. The vaccine is ...
Meningococcal Meningitis · 1.At present, only one of meningococcal vaccines is specially imported for use in Taiwan –Meningococcal conjugate vaccine (MCV4, ...
2023年11月20日 — Trumenba: Vaccine providers give a 2-dose series to people 16 through 23 years old who are not at increased risk of meningococcal disease.
Immunity following meningococcal infection is sero-group-specific. Current internationally marketed meningococcal vaccines are based either on combinations of ...
The meningococcal conjugate vaccine (MenACWY) protects against four types of meningococcal bacteria (types A, C, W, and Y). · The meningococcal B vaccine (MenB) ...